MLAB (STOCKS)
Mesa Laboratories Inc
$91.230000
-0.720000 (-0.78%)
Prev close: $91.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Gary M. Owens
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $503.31M
- Employees
- 730
- P/E (TTM)
- 142.43
- P/B (TTM)
- 2.72
- Dividend Yield
- 69.60%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q3)
|
$0.65 | $0.28 | +0.3678 | +130.33% |
|
Sep 2025 (Q2)
|
$0.45 | $0.16 | +0.2868 | +175.74% |
|
Jun 2025 (Q1)
|
$0.85 | $0.45 | +0.4046 | +90.84% |
|
Mar 2025 (Q4)
|
$-1.31 | $1.11 | -2.4218 | -217.83% |
Financial Statements
| Revenues | $247.54M |
| Benefits Costs and Expenses | $233.47M |
| Cost Of Revenue | $93.06M |
| Costs And Expenses | $233.47M |
| Gross Profit | $154.48M |
| Nonoperating Income/Loss | -$3.16M |
| Operating Expenses | $137.25M |
| Research and Development | $20.16M |
| Other Operating Expenses | $117.09M |
| Operating Income/Loss | $17.23M |
| Income/Loss From Continuing Operations After Tax | $11.67M |
| Income/Loss From Continuing Operations Before Tax | $14.07M |
| Income Tax Expense/Benefit | $10.33M |
| Net Income/Loss | $3.73M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $3.73M |
| Net Income/Loss Available To Common Stockholders, Basic | $3.73M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.66 |
| Diluted Earnings Per Share | $0.65 |
| Basic Average Shares | 5,512,000 |
| Diluted Average Shares | 5,509,000 |
| Common Stock Dividends | $0.64 |
| Assets | $434.85M |
| Current Assets | $105.63M |
| Inventory | $26.56M |
| Other Current Assets | $79.07M |
| Noncurrent Assets | $329.22M |
| Fixed Assets | $31.60M |
| Other Non-current Assets | $297.62M |
| Liabilities | $248.16M |
| Current Liabilities | $54.40M |
| Accounts Payable | $5.25M |
| Wages | $13.88M |
| Other Current Liabilities | $35.26M |
| Noncurrent Liabilities | $193.76M |
| Long-term Debt | $68.44M |
| Other Non-current Liabilities | $125.33M |
| Equity | $186.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $186.69M |
| Liabilities And Equity | $434.85M |
| Net Cash Flow From Operating Activities | $41.53M |
| Net Cash Flow From Operating Activities, Continuing | $41.53M |
| Net Cash Flow From Investing Activities | -$3.84M |
| Net Cash Flow From Investing Activities, Continuing | -$3.84M |
| Net Cash Flow From Financing Activities | -$42.29M |
| Net Cash Flow From Financing Activities, Continuing | -$42.29M |
| Net Cash Flow | -$4.59M |
| Net Cash Flow, Continuing | -$4.59M |
| Comprehensive Income/Loss | $19.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $19.22M |
| Other Comprehensive Income/Loss | $19.22M |